Stock data
Cocrystal Pharma, Inc. (COCP)
Cocrystal Pharma, Inc. (COCP) reported net income of -US$8.83M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$9.02M | -US$8.83M | — |
| 2024 | — | — | -US$17.88M | -US$17.50M | — |
| 2023 | — | — | -US$18.56M | -US$17.98M | — |
| 2022 | — | — | -US$38.83M | -US$38.84M | — |
| 2021 | — | — | -US$14.22M | -US$14.19M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.10M | -US$3.16M | — |
| 2026-03-31 | US$0.23M | -US$2.30M | — |
| 2025-12-31 | — | -US$2.43M | — |
| 2025-09-30 | — | -US$2.05M | — |
| 2025-06-30 | — | -US$2.06M | — |
| 2025-03-31 | — | -US$2.30M | — |
| 2024-12-31 | — | -US$3.27M | — |
| 2024-09-30 | — | -US$4.94M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.